Search for: "Roche Pharmaceuticals Inc."
Results 101 - 120
of 222
Sort by Relevance
|
Sort by Date
24 Feb 2011, 11:11 am
Roche Molecular Systems, Inc., to be argued February 28, 2011, presents a classic conflict between text and policy. [read post]
11 Feb 2011, 7:51 am
Rost performs expert witness testimony: Patent Infringement, Pharmaceutical Marketing, Drug Product Liability, Drug Marketing and Promotion, Drug Sales. [read post]
8 Feb 2011, 10:51 pm
(FDA Law Blog) US: Another academic with solutions to problems that don’t exist (Patent Docs) US: Syngenta files for declaratory judgment of invalidity and non-infringement of Bayer’s patents based on its development of GM crops containing HPPD gene (Patent Docs) US: District Court New Jersey: Loss of market share to infringing competitor during six year reexamination warrants denial of stay: Wyeth et al v Abbott (Docket Report) US: District Court New Jersey: Court precludes jury… [read post]
20 Jan 2011, 12:50 pm
Hoffmann-La Roche, Inc., 891 A.2d 1229, 1236 (N.J. [read post]
3 Jan 2011, 9:45 pm
Pharmaceuticals: GLAXO AND SUBSIDIARY SETTLE CIVIL, CRIMINAL CASES FOR $750 MILLION, United States v. [read post]
29 Dec 2010, 2:57 am
Ferring Pharmaceuticals, Inc et al. [read post]
8 Dec 2010, 2:20 am
– Nova Biomedical fight for survival following patent threats from Abbott, Roche, Medtronic (IP Directions) Pathogens and the Nagoya Protocol of the Convention on Biological Diversity (PatentlyBIOtech) Australia: Federal Court punishes CSL for amendment delay: CSL Limited v Novo Nordisk Pharmaceuticals Pty Ltd (Patentology) Australia: AusBiotech, legal academics and ARDR weigh in on gene patent debate (Patentology) Australia: Gene patent amendment bill introduced (IP… [read post]
9 Nov 2010, 10:46 am
Roche Molecular Sys., Inc., 583 F.3d 832 (Fed. [read post]
3 Nov 2010, 11:24 am
”); Roche Prods., Inc. v. [read post]
3 Nov 2010, 1:21 am
Highlights this week included: US Supreme Court to hear Bayh-Dole patent ownership dispute: Stanford v Roche (Patently-O) (IPKat) (IPBiz) US DoJ amicus brief in Myriad says no to patentability of genomic DNA: AMP v USPTO (IPBiz) (Inventive Step) (Patently-O) (Patent Docs) (Holman’s Biotech IP Blog) Gemzar (Gemcitabine) – US: CAFC denies en banc rehearing of ‘distorted’ law of double-patenting: Sun Pharmaceuticals v Eli Lilly (Peter Zura’s 271 Patent… [read post]
15 Oct 2010, 5:29 am
Rossa McMahon (A Clatter of the Law) has done the entire IP world a favour by condensing the enormous Irish Court ruling of Mr Justice Feeney in Koger Inc. [read post]
12 Oct 2010, 8:56 pm
Highlights this week included: Aricept(Donepezil) –US: Declaratory judgment jurisdiction for subsequent Paragraph IV filers: Teva Pharmaceuticals USA, Inc. v. [read post]
2 Oct 2010, 8:43 am
Peter Rost is a former Pfizer Marketing Vice President providing services as an expert witness on pharmaceutical marketing and consulting services on corporate therapeutics and ethics guidelines. [read post]
28 Sep 2010, 3:14 pm
Teva Pharmaceuticals USA Inc. et al. [read post]
7 Sep 2010, 6:10 pm
Patent and Trademark Office et. al, (Prior Art) US: District Court New Jersey: Drug label may provide evidence of intent to induce infringement even though required by the FDA: Hoffmann-La Roche Inc. v. [read post]
25 Aug 2010, 12:37 am
Watson Pharma, Inc. et al. [read post]
28 Jul 2010, 12:06 am
Teva Pharmaceuticals USA, Inc. [read post]
26 Jul 2010, 10:41 pm
Roche Laboratories is already producing and marketing a new test called the “AmpliChip CYP450”. [read post]
25 Jul 2010, 9:14 pm
Lupin Pharmaceuticals, Inc. et al. 1:10-cv-01988; filed July 20, 2010 in the District Court of Maryland • Plaintiffs: Roche Palo Alto LLC; Gilead Palo Alto, Inc.; Gilead Sciences, Inc. [read post]
21 Jul 2010, 1:05 am
Biogaran and Laboratoires Medidom (EPLAW) Fortical (Calcitonin) – US: Unigene secures ruling of infringement against Apotex in Fortical patent suit (Patent Docs) Levaquin (Levofloxacin) – US: Federal Circuit denies rehearing petition in Levaquin Patent Term Extension case: Ortho-McNeil Pharmaceutical, Inc. v. [read post]
